Clinical Trial Update: Optimizing Linezolid Dosing in Patients With Advanced Renal Impairment: a Therapeutic Drug Monitoring-based Evaluation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating therapeutic drug monitoring-based dosing of linezolid in patients with advanced renal impairment to optimize exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: Alexandria University | Conditions: Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING